Advertisement

Harvard, MIT Students Host, Challenge Biotechnology Luminaries

"The human genome should not be corporate property," he said.

According to Claudia Mickelson, chair of the National Institutes of Health Recombinant DNA Advisory Committee, citizens should be aware of the evidence used in forming government policy.

"I feel very strongly that for there to be public trust in these technologies, we must have publicly accessible information," she said.

Advertisement

In his Sunday evening keynote address, Campbell echoed the idea that the public should have access to the research that informs scientific decision-making.

"It's the lack of accountability that people are most worried about, if you are accountable to investors and not to the public," he said.

New Technology

In addition to the political and scientific controversies at the conference, there was also much talk about the frontiers of biotechnology.

Langer, chair of the U.S. Food and Drug Administration's highest advisory board, detailed his plans for the delivery of drugs to patients on synthetic chips. These chips will regulate the dosage of drugs better than is now possible with pills.

Recommended Articles

Advertisement